Hepcidin detects iron deficiency in Sri Lankan adolescents with a high burden of hemoglobinopathy: A diagnostic test accuracy study

American Journal of Hematology

Volumn 92, Issue 2, 2017, Pages 196-203

  Wray, Katherine ^a,b   Allen, Angela ^c   Evans, Emma ^d   Fisher, Chris ^a   Premawardhena, Anuja ^e   Perera, Lakshman ^e   Rodrigo, Rexan ^e   Goonathilaka, Gayan ^e   Ramees, Lebbe ^e   Webster, Craig ^d   Armitage, Andrew E ^a   Prentice, Andrew M ^f,g   Weatherall, David J ^a   Drakesmith, Hal ^a,b   Pasricha, Sant Rayn ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^d BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^e UNIVERSITY OF KELANIYA   (Sri Lanka)

^f MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^g MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEMOGLOBIN; HEPCIDIN; TRANSFERRIN RECEPTOR;

ADOLESCENT; ALPHA THALASSEMIA; ARTICLE; BETA THALASSEMIA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEMOGLOBINOPATHY; HUMAN; IRON DEFICIENCY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SRI LANKAN; YOUDEN INDEX; ANEMIA, IRON-DEFICIENCY; BLOOD; CHILD; COMPLICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; SRI LANKA; YOUNG ADULT;

ADOLESCENT; ANEMIA, IRON-DEFICIENCY; CHILD; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOGLOBINOPATHIES; HEMOGLOBINS; HEPCIDINS; HUMANS; MALE; SENSITIVITY AND SPECIFICITY; SRI LANKA; YOUNG ADULT;

EID: 85009821135     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.24617     Document Type: Article

References (30)

1. World Health Organization. The global prevalence of anaemia in 2011. Geneva: World Health Organization; 2015.
2. World Health Organization. Prevention of Iron Deficiency Anaemia in Adolescents - Role of Weekly Iron Folic Acid Supplementation. New Delhi: World Health Organization - Regional Office for South East Asia; 2011.
3. India MoHaFW-Go. WIFS. New Delhi: Government of India; 2013.
4. Thurlow RA, Winichagoon P, Green T, et al. Only a small proportion of anemia in northeast Thai schoolchildren is associated with iron deficiency. Am J Clin Nutr. 2005;82:380–387.
5. de Silva S, Fisher CA, Premawardhena A, et al. Thalassaemia in Sri Lanka: implications for the future health burden of Asian populations. Lancet. 2000;355:786–791.
6. Sazawal S, Black RE, Ramsan M, et al. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet. 2006;367:133–143.
7. Jaeggi T, Kortman GA, Moretti D, et al. Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants. Gut. 2015;64:731–742.
8. Ganz T. Systemic iron homeostasis. Physiol Rev. 2013;93:1721–1741.
9. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090–2093.
10. Jones E, Pasricha SR, Allen A, et al. Hepcidin is suppressed by erythropoiesis in hemoglobin E beta-thalassemia and beta-thalassemia trait. Blood. 2015;125:873–880.
11. Zimmermann MB, Fucharoen S, Winichagoon P, et al. Iron metabolism in heterozygotes for hemoglobin E (HbE), alpha-thalassemia 1, or beta-thalassemia and in compound heterozygotes for HbE/beta-thalassemia. Am J Clin Nutr. 2008;88:1026–1031.
12. Girelli D, Nemeth E, Swinkels DW. Hepcidin in the diagnosis of iron disorders. Blood. 2016;127:2809–2813.
13. Pasricha SR, Atkinson SH, Armitage AE, et al. Expression of the iron hormone hepcidin distinguishes different types of anemia in African children. Sci Transl Med. 2014;6:235re233.
14. Premawardhena A, Allen A, Piel F, et al. The evolutionary and clinical implications of the uneven distribution of the frequency of the inherited haemoglobin variants over short geographical distances. Br J Haematol (in press).
15. Chong SS, Boehm CD, Higgs DR, et al. Single-tube multiplex-PCR screen for common deletional determinants of alpha-thalassemia. Blood. 2000;95:360–362.
16. van der Vorm LN, Hendriks JC, Laarakkers CM, et al. Toward worldwide hepcidin assay harmonization: identification of a commutable secondary reference material. Clin Chem. 2016;62:993–1001.
17. World Health Organization. Serum ferritin concentrations for the assessment of iron status and iron deficiency in populations. Vitamin and Mineral Nutrition Information System. Geneva; 2011.
18. Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood. 1997;89:1052–1057.
19. Atkinson SH, Armitage AE, Khandwala S, et al. Combinatorial effects of malaria season, iron deficiency, and inflammation determine plasma hepcidin concentration in African children. Blood. 2014;123:3221–3229.
20. Galesloot TE, Vermeulen SH, Geurts-Moespot AJ, et al. Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood. 2011;117:e218–e225.
21. Zimmermann MB, Troesch B, Biebinger R, et al. Plasma hepcidin is a modest predictor of dietary iron bioavailability in humans, whereas oral iron loading, measured by stable-isotope appearance curves, increases plasma hepcidin. Am J Clin Nutr. 2009;90:1280–1287.
22. Prentice AM, Doherty CP, Abrams SA, et al. Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children. Blood. 2012.
23. Choi HS, Song SH, Lee JH, et al. Serum hepcidin levels and iron parameters in children with iron deficiency. Korean J Hematol. 2012;47:286–292.
24. Sanad M, Gharib AF. Urinary hepcidin level as an early predictor of iron deficiency in children: a case control study. Ital J Pediatr. 2011;37:37.
25. Pasricha SR, McQuilten Z, Westerman M, et al. Serum hepcidin as a diagnostic test of iron deficiency in premenopausal female blood donors. Haematologica 2011;96:1099–1105.
26. Wolff F, Gentelet M, Gulbis B, et al. Hepcidin on 24-hour urine collection: preanalytical aspects and correlation with ferritin levels. Scand J Clin Lab Invest. 2016;1–6.
27. Gardenghi S, Marongiu MF, Ramos P, et al. Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. Blood. 2007;109:5027–5035.
28. Garcia-Casal MN, Pena-Rosas JP, Pasricha SR. Rethinking ferritin cutoffs for iron deficiency and overload. Lancet Haematol. 2014;1:e92–e94.
29. Wegmuller R, Bah A, Kendall L, et al. Efficacy and safety of hepcidin-based screen-and-treat approaches using two different doses versus a standard universal approach of iron supplementation in young children in rural Gambia: a double-blind randomised controlled trial. BMC Pediatr. 2016;16:149.
30. Bah A, Wegmuller R, Cerami C, et al. A double blind randomised controlled trial comparing standard dose of iron supplementation for pregnant women with two screen-and-treat approaches using hepcidin as a biomarker for ready and safe to receive iron. BMC Pregn Childbirth. 2016;16:157.